GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis

Hormones and Behavior

Volumn 76, Issue , 2015, Pages 136-142

  Gafford, Georgette M ^a,b   Ressler, Kerry J ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Georgia State University   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Amygdala; Anxiety; BNST; CRF; Extinction; Fear; GABA; NMDA; PTSD; R121919

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID RECEPTOR; CORTICOTROPIN RELEASING FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

ANXIETY; CENTRAL NUCLEUS (AMYGDALA); CEREBROSPINAL FLUID LEVEL; CONDITIONING; FEAR; GABAA ALPHA1 GENE; GABAERGIC TRANSMISSION; GENE EXPRESSION; HUMAN; MEMORY; NERVE CELL; NMDAR1 GENE; NONHUMAN; PHENOTYPE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REINFORCEMENT; REVIEW; STIMULUS RESPONSE; STRESS; STRIA TERMINALIS; ANIMAL; METABOLISM; PHYSIOLOGY; SEPTUM NUCLEUS;

ANIMALS; ANXIETY; CENTRAL AMYGDALOID NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; FEAR; HUMANS; NEURONS; RECEPTORS, GABA; RECEPTORS, N-METHYL-D-ASPARTATE; SEPTAL NUCLEI;

EID: 84947863915     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2015.04.001     Document Type: Review

References (89)

1. Abiri D., Douglas C.E., Calakos K.C., Barbayannis G., Roberts A., Bauer E.P. Fear extinction learning can be impaired or enhanced by modulation of the CRF system in the basolateral nucleus of the amygdala. Behav. Brain Res. 2014, 271:234-239.
2. Alheid G.F., Beltramino C.A., De Olmos J.S., Forbes M.S., Swanson D.J., Heimer L. The neuronal organization of the supracapsular part of the stria terminalis in the rat: the dorsal component of the extended amygdala. Neuroscience 1998, 84:967-996.
3. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., Bruce A.B., Orth D.N., Geracioti T.D. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 1999, 156:585-588.
4. Bale T.L. Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm. Behav. 2005, 48:1-10.
5. Baram T.Z., Hatalski C.G. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci. 1998, 21:471-476.
6. Blechert J., Michael T., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behav. Res. Ther. 2007, 45:2019-2033.
7. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., Nemeroff C.B., Charney D.S. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 1997, 154:624-629.
8. Britton D.R., Koob G.F., Rivier J., Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 1982, 31:363-367.
9. Cahill L., Gorski L., Le K. Enhanced human memory consolidation with post-learning stress: interaction with the degree of arousal at encoding. Learn. Mem. (Cold Spring Harb. N. Y.) 2003, 10:270-274.
10. Callahan L.B., Tschetter K.E., Ronan P.J. Inhibition of corticotropin releasing factor expression in the central nucleus of the amygdala attenuates stress-induced behavioral and endocrine responses. Front. Neurosci. 2013, 7:195.
11. Campeau S., Davis M. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J. Neurosci. 1995, 15:2301-2311.
12. Chen Y., Brunson K.L., Muller M.B., Cariaga W., Baram T.Z. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 2000, 420:305-323.
13. Choi D.C., Nguyen M.M., Tamashiro K.L., Ma L.Y., Sakai R.R., Herman J.P. Chronic social stress in the visible burrow system modulates stress-related gene expression in the bed nucleus of the stria terminalis. Physiol. Behav. 2006, 89:301-310.
14. Cole B.J., Koob G.F. Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor. J. Pharmacol. Exp. Ther. 1988, 247:902-910.
15. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35:105-135.
16. Difede J., Cukor J., Wyka K., Olden M., Hoffman H., Lee F.S., Altemus M. d-Cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology 2014, 39:1052-1058.
17. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain Res. Rev. 2001, 38:192-246.
18. Duvarci S., Pare D. Amygdala microcircuits controlling learned fear. Neuron 2014, 82:966-980.
19. Funk D., Li Z., Le A.D. Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: Relationship to the reinstatement of alcohol seeking. Neuroscience 2006, 138:235-243.
20. Furini C., Myskiw J., Izquierdo I. The learning of fear extinction. Neurosci. Biobehav. Rev. 2014, 47C:670-683.
21. Gafford G.M., Guo J.D., Flandreau E.I., Hazra R., Rainnie D.G., Ressler K.J. Cell-type specific deletion of GABA(A)alpha1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:16330-16335.
22. Gafford G., Jasnow A.M., Ressler K.J. Grin1 receptor deletion within CRF neurons enhances fear memory. PLoS One 2014, 9:e111009.
23. Glover E.M., Phifer J.E., Crain D.F., Norrholm S.D., Davis M., Bradley B., Ressler K.J., Jovanovic T. Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures. Depress. Anxiety 2011, 28:1058-1066.
24. Goosens K.A., Maren S. Pretraining NMDA receptor blockade in the basolateral complex, but not the central nucleus, of the amygdala prevents savings of conditional fear. Behav. Neurosci. 2003, 117:738-750.
25. Gray T.S., Magnuson D.J. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J. Comp. Neurol. 1987, 262:365-374.
26. Gray T.S., Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 1992, 13:451-460.
27. Heldt S.A., Ressler K.J. Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience 2007, 150:370-385.
28. Hensch T.K. Critical period plasticity in local cortical circuits. Nat. Rev. Neurosci. 2005, 6:877-888.
29. Hitchcock J.M., Davis M. Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav. Neurosci. 1991, 105:826-842.
30. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., Gustafsson J.A., Wikstrom A.C., Hokfelt T. Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology 1992, 55:451-459.
31. Hubbard D.T., Nakashima B.R., Lee I., Takahashi L.K. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience 2007, 150:818-828.
32. Hui I.R., Hui G.K., Roozendaal B., McGaugh J.L., Weinberger N.M. Posttraining handling facilitates memory for auditory-cue fear conditioning in rats. Neurobiol. Learn. Mem. 2006, 86:160-163.
33. Isogawa K., Bush D.E., LeDoux J.E. Contrasting effects of pretraining, posttraining, and pretesting infusions of corticotropin-releasing factor into the lateral amygdala: attenuation of fear memory formation but facilitation of its expression. Biol. Psychiatry 2013, 73:353-359.
34. Johansen J.P., Cain C.K., Ostroff L.E., LeDoux J.E. Molecular mechanisms of fear learning and memory. Cell 2011, 147:509-524.
35. Kapcala L.P., Dicke J.A. Brain corticotropin-releasing hormone receptors on neurons and astrocytes. Brain Res. 1992, 589:143-148.
36. Kim S.J., Park S.H., Choi S.H., Moon B.H., Lee K.J., Kang S.W., Lee M.S., Choi S.H., Chun B.G., Shin K.H. Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. Neuropharmacology 2006, 50:824-833.
37. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 1978, 178:225-254.
38. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
39. LeDoux J.E., Sakaguchi A., Iwata J., Reis D.J. Auditory emotional memories: establishment by projections from the medial geniculate nucleus to the posterior neostriatum and/or dorsal amygdala. Ann. N. Y. Acad. Sci. 1985, 444:463-464.
40. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 1988, 8:2517-2529.
41. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 1997, 17:6434-6446.
42. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
43. Lein E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
44. Liang K.C., Lee E.H. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology (Berl.) 1988, 96:232-236.
45. Lissek S., Powers A.S., McClure E.B., Phelps E.A., Woldehawariat G., Grillon C., Pine D.S. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav. Res. Ther. 2005, 43:1391-1424.
46. Martin E.I., Ressler K.J., Jasnow A.M., Dabrowska J., Hazra R., Rainnie D.G., Nemeroff C.B., Owens M.J. A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol. Psychiatry 2010, 67:1212-1216.
47. Merchenthaler I. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984, 5(Suppl. 1):53-69.
48. Myers K.M., Davis M. Mechanisms of fear extinction. Mol. Psychiatry 2007, 12:120-150.
49. Nemeroff C.B., Bremner J.D., Foa E.B., Mayberg H.S., North C.S., Stein M.B. Posttraumatic stress disorder: a state-of-the-science review. J. Psychiatr. Res. 2006, 40:1-21.
50. Orr S.P., Metzger L.J., Lasko N.B., Macklin M.L., Peri T., Pitman R.K. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J. Abnorm. Psychol. 2000, 109:290-298.
51. Palkovits M., Brownstein M.J., Vale W. Distribution of corticotropin-releasing factor in rat brain. Fed. Proc. 1985, 44:215-219.
52. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol. Rev. 2010, 90:419-463.
53. Pare D., Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr. Opin. Neurobiol. 2012, 22:717-723.
54. Peri T., Ben-Shakhar G., Orr S.P., Shalev A.Y. Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder. Biol. Psychiatry 2000, 47:512-519.
55. Pitkanen A., Stefanacci L., Farb C.R., Go G.G., LeDoux J.E., Amaral D.G. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. J. Comp. Neurol. 1995, 356:288-310.
56. Pitts M.W., Takahashi L.K. The central amygdala nucleus via corticotropin-releasing factor is necessary for time-limited consolidation processing but not storage of contextual fear memory. Neurobiol. Learn. Mem. 2011, 95:86-91.
57. Pitts M.W., Todorovic C., Blank T., Takahashi L.K. The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory. J. Neurosci. 2009, 29:7379-7388.
58. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8777-8781.
59. Rau V., DeCola J.P., Fanselow M.S. Stress-induced enhancement of fear learning: an animal model of posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2005, 29:1207-1223.
60. Risbrough V.B., Stein M.B. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm. Behav. 2006, 50:550-561.
61. Roberts G.W., Woodhams P.L., Polak J.M., Crow T.J. Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience 1982, 7:99-131.
62. Roozendaal B., Brunson K.L., Holloway B.L., McGaugh J.L., Baram T.Z. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13908-13913.
63. Roozendaal B., Schelling G., McGaugh J.L. Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation. J. Neurosci. 2008, 28:6642-6651.
64. Rosen J.B., Hitchcock J.M., Sananes C.B., Miserendino M.J., Davis M. A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav. Neurosci. 1991, 105:817-825.
65. Rothbaum B.O., Davis M. Applying learning principles to the treatment of post-trauma reactions. Ann. N. Y. Acad. Sci. 2003, 1008:112-121.
66. Rothbaum B.O., Price M., Jovanovic T., Norrholm S.D., Gerardi M., Dunlop B., Davis M., Bradley B., Duncan E.J., Rizzo A., Ressler K.J. A randomized, double-blind evaluation of d-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am. J. Psychiatry 2014, 171:640-648.
67. Sahuque L.L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., Janak P.H., Olive M.F. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl.) 2006, 186:122-132.
68. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 1986, 382:213-238.
69. Sautter F.J., Bissette G., Wiley J., Manguno-Mire G., Schoenbachler B., Myers L., Johnson J.E., Cerbone A., Malaspina D. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol. Psychiatry 2003, 54:1382-1388.
70. Sawchenko P.E., Swanson L.W. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed. Proc. 1985, 44:221-227.
71. Shen Q., Fuchs T., Sahir N., Luscher B. GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice. PLoS One 2012, 7:e47441.
72. Shepard J.D., Schulkin J., Myers D.A. Chronically elevated corticosterone in the amygdala increases corticotropin releasing factor mRNA in the dorsolateral bed nucleus of stria terminalis following duress. Behav. Brain Res. 2006, 174:193-196.
73. Sherman J.E., Kalin N.H. ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity. Pharmacol. Biochem. Behav. 1988, 30:801-807.
74. Sink K.S., Walker D.L., Yang Y., Davis M. Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J. Neurosci. 2011, 31:1802-1810.
75. Sink K.S., Walker D.L., Freeman S.M., Flandreau E.I., Ressler K.J., Davis M. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol. Psychiatry 2013, 18:308-319.
76. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004, 128:7-14.
77. Sun N., Cassell M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol. 1993, 330:381-404.
78. Swiergiel A.H., Takahashi L.K., Kalin N.H. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res. 1993, 623:229-234.
79. Takahashi L.K., Kalin N.H., Vanden Burgt J.A., Sherman J.E. Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav. Neurosci. 1989, 103:648-654.
80. Thompson B.L., Erickson K., Schulkin J., Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav. Brain Res. 2004, 149:209-215.
81. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
82. VanElzakker M.B., Dahlgren M.K., Davis F.C., Dubois S., Shin L.M. From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders. Neurobiol. Learn. Mem. 2014, 113:3-18.
83. Waddell J., Morris R.W., Bouton M.E. Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav. Neurosci. 2006, 120:324-336.
84. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 1997, 17:9375-9383.
85. Walker D.L., Ressler K.J., Lu K.T., Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J. Neurosci. 2002, 22:2343-2351.
86. Walker D.L., Miles L.A., Davis M. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2009, 33:1291-1308.
87. Wilensky A.E., Schafe G.E., Kristensen M.P., LeDoux J.E. Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J. Neurosci. 2006, 26:12387-12396.
88. Woodhams P.L., Roberts G.W., Polak J.M., Crow T.J. Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience 1983, 8:677-703.
89. Zimmerman J.M., Maren S. NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats. Eur. J. Neurosci. 2010, 31:1664-1670.